These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 5477888)

  • 21. Phosphofructokinase (PFK) regulation of glycolysis in psoriatic epidermis.
    Kondo S; Gerna-Torsellini M
    J Invest Dermatol; 1974 May; 62(5):503-6. PubMed ID: 4274668
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cytophotometric investigations on the dns and total protein content in cells of normal skin and latent psoriatic epidermis cultivated in vitro].
    Ehlers G; Gründer K; Wohlrab W
    Arch Dermatol Forsch; 1974 Apr; 249(3):255-67. PubMed ID: 4840893
    [No Abstract]   [Full Text] [Related]  

  • 23. The pentose phosphte pathway in human and animal skin.
    Jarret A
    Br J Dermatol; 1971 Jun; 84(6):545-53. PubMed ID: 5557510
    [No Abstract]   [Full Text] [Related]  

  • 24. Histopathology and histochemistry of psoriasis. I. The active lesion and clinically normal skin.
    Gordon M; Johnson WC
    Arch Dermatol; 1967 Apr; 95(4):402-7. PubMed ID: 6023045
    [No Abstract]   [Full Text] [Related]  

  • 25. Cyclic adenosine monophosphate, adenyl cyclase and cyclic nucleotide phosphodiesterase in psoriatic epidermis, with a comment on urinary cAMP.
    Härkönen M; Hopsu-Havu VK; Raij K
    Acta Derm Venereol; 1974; 54(1):13-8. PubMed ID: 4135160
    [No Abstract]   [Full Text] [Related]  

  • 26. Localization of proteolytic activity in psoriatic skin.
    Dubertret L; Bertaux B; Fosse M; Touraine R
    Br J Dermatol; 1982 Nov; 107(5):499-504. PubMed ID: 6751371
    [No Abstract]   [Full Text] [Related]  

  • 27. [Comparative study of normal and psoriatic skin using a micromethod for detection of enzymatic activity].
    Garidelli de Quincenet G; Laviolette P; Ortonne JP; Arnoux D
    Ann Dermatol Venereol; 1980; 107(12):1163-70. PubMed ID: 6263165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The DNA content of epidermal cells in non-involved psoriatic skin].
    Wohlrab W
    Dermatologica; 1970; 141(1):28-33. PubMed ID: 5471380
    [No Abstract]   [Full Text] [Related]  

  • 29. [Latent psoriasis].
    Mordovtsev VN; Keshileva-Nurlanova Z; Liagushkina MP
    Vestn Dermatol Venerol; 1975 Dec; (12):11-6. PubMed ID: 1229665
    [No Abstract]   [Full Text] [Related]  

  • 30. "Psoriasis as a possible defect of the adenyl cyclase-cyclic AMP Cascade" by Voorhees and Duell, October 1971. Commentary: Cyclic adenosine monophosphate regulation of normal and psoriatic epidermis.
    Voorhees JJ
    Arch Dermatol; 1982 Oct; 118(10):862-74. PubMed ID: 6182841
    [No Abstract]   [Full Text] [Related]  

  • 31. [Changes in the acid and alkaline phosphatase and acid hyaluronidase activities in skin homogenates in psoriasis].
    Mushet GV
    Vestn Dermatol Venerol; 1983 Nov; (11):38-40. PubMed ID: 6670370
    [No Abstract]   [Full Text] [Related]  

  • 32. Metabolic dynamics in psoriatic epidermis: Enhanced glucose and lactate uptake, glycolytic pathway and TCA cycle dynamics.
    Nakamizo S; Doi H; Kabashima K
    Exp Dermatol; 2024 Jul; 33(7):e15127. PubMed ID: 38973262
    [No Abstract]   [Full Text] [Related]  

  • 33. FITC-insulin binding to normal and psoriatic epidermis.
    Wollina U; Hipler C; Knopf B
    Acta Histochem; 1989; 85(2):223-6. PubMed ID: 2500831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparative quantitative and histotopochemical examinations on phosphomonoesterases in the clinical unaffected skin of psoriatics].
    Wohlrab W; Peker J; Marculescu J
    Dermatol Monatsschr; 1970; 156(5):481-3. PubMed ID: 4323997
    [No Abstract]   [Full Text] [Related]  

  • 35. [Distribution and activity of phosphomonoesterases in the cutis of unaffected psoriatic skin].
    Wohlrab W; Peker J; Zaumseil RP
    Dermatologica; 1970; 141(1):21-7. PubMed ID: 4319472
    [No Abstract]   [Full Text] [Related]  

  • 36. Lactic dehydrogenase activity in human epidermis: semiquantitative histochemical study.
    Sasai Y
    Tohoku J Exp Med; 1972 Dec; 108(4):327-36. PubMed ID: 4664256
    [No Abstract]   [Full Text] [Related]  

  • 37. Arginase 1 overexpression in psoriasis: limitation of inducible nitric oxide synthase activity as a molecular mechanism for keratinocyte hyperproliferation.
    Bruch-Gerharz D; Schnorr O; Suschek C; Beck KF; Pfeilschifter J; Ruzicka T; Kolb-Bachofen V
    Am J Pathol; 2003 Jan; 162(1):203-11. PubMed ID: 12507903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased deiminated keratin K1 in psoriatic hyperproliferative epidermis.
    Ishida-Yamamoto A; Senshu T; Takahashi H; Akiyama K; Nomura K; Iizuka H
    J Invest Dermatol; 2000 Apr; 114(4):701-5. PubMed ID: 10733676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of phospholipase A activity in psoriatic skin.
    Cantelmi A; Gaiti A; Porcellati G; Ansidei V; Binazzi M
    Farmaco Sci; 1982 Sep; 37(9):612-7. PubMed ID: 6813141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular changes in the psoriatic epidermis. V. The submicroscopic intracellular distribution of mercury compound in the psoriatic epidermis.
    Lagerholm B; Frithz A
    Acta Derm Venereol; 1967; 47(4):222-36. PubMed ID: 4166057
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.